This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

U.S. District Court: Northern District of Georgia - Federal Trade Commission v. Watson Pharmaceuticals et al [appellant reply brief]

( December 15, 2010, 23:00 GMT | Official Statement) -- MLex Summary: The Federal Trade Commission has submitted its reply brief in its appeal of a district court decision dismissing its pay-for-delay case involving AndroGel. The FTC argues that the district court and defendants have misinterpreted the precedents on which they rely, and that the likelihood that a patent-holder will succeed in an infringement suit is relevant to the analysis. The agency also argues that if the precedents are construed as the defendants suggest, the court should reevaluate the decisions in those cases en banc.See brief below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections